Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BCG vaccine - Vakzine Projekt Management/Serum Institute of India

Drug Profile

BCG vaccine - Vakzine Projekt Management/Serum Institute of India

Alternative Names: BCG-vaccine-Vakzine-Projekt-Management; rBCG-delta-ureC-Hly; rBCGdeltaUreCHly; VPM-1002; VPM-1002BC

Latest Information Update: 03 May 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Max Planck Institute for Infection Biology
  • Developer Serum Institute of India; Swiss Group for Clinical Cancer Research; Vakzine Projekt Management
  • Class Antituberculars; Tuberculosis vaccines; Vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Tuberculosis
  • Phase I/II Bladder cancer

Most Recent Events

  • 15 Dec 2017 Phase-II/III clinical trials in Tuberculosis (Prevention, In volunteers) in India (Intradermal) (CTRI2017-03-008266)
  • 04 Nov 2017 No recent reports of development identified for phase-I development in Tuberculosis(Prevention) in Germany (IM, Injection)
  • 04 May 2017 Serum Institute of India plans a phase II/III trial for Tuberculosis (Prevention, In volunteers) in India (Intradermal) (CTRI2017-03-008266)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top